143 related articles for article (PubMed ID: 15661561)
1. The dilemma of the strive for apoptosis in oncology: mind the heart.
Perik PJ; de Vries EG; Gietema JA; van der Graaf WT; Sleijfer DT; Suurmeijer AJ; van Veldhuisen DJ
Crit Rev Oncol Hematol; 2005 Feb; 53(2):101-13. PubMed ID: 15661561
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in understanding the cell death pathways activated by anticancer therapy.
Kim R
Cancer; 2005 Apr; 103(8):1551-60. PubMed ID: 15742333
[TBL] [Abstract][Full Text] [Related]
3. Regulation of death receptors--relevance in cancer therapies.
de Thonel A; Eriksson JE
Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):123-32. PubMed ID: 16126242
[TBL] [Abstract][Full Text] [Related]
4. Effects of left ventricular volume overload on mitochondrial and death-receptor-mediated apoptotic pathways in the transition to heart failure.
Moorjani N; Westaby S; Narula J; Catarino PA; Brittin R; Kemp TJ; Narula N; Sugden PH
Am J Cardiol; 2009 May; 103(9):1261-8. PubMed ID: 19406269
[TBL] [Abstract][Full Text] [Related]
5. The control of cardiomyocyte apoptosis via the beta-adrenergic signaling pathways.
Communal C; Colucci WS
Arch Mal Coeur Vaiss; 2005 Mar; 98(3):236-41. PubMed ID: 15816327
[TBL] [Abstract][Full Text] [Related]
6. Myocyte apoptosis in heart failure.
van Empel VP; Bertrand AT; Hofstra L; Crijns HJ; Doevendans PA; De Windt LJ
Cardiovasc Res; 2005 Jul; 67(1):21-9. PubMed ID: 15896727
[TBL] [Abstract][Full Text] [Related]
7. Fas/CD95 death receptor and lipid rafts: new targets for apoptosis-directed cancer therapy.
Mollinedo F; Gajate C
Drug Resist Updat; 2006; 9(1-2):51-73. PubMed ID: 16687251
[TBL] [Abstract][Full Text] [Related]
8. Directing cancer cells to self-destruct with pro-apoptotic receptor agonists.
Ashkenazi A
Nat Rev Drug Discov; 2008 Dec; 7(12):1001-12. PubMed ID: 18989337
[TBL] [Abstract][Full Text] [Related]
9. Oxidative stress by monoamine oxidase mediates receptor-independent cardiomyocyte apoptosis by serotonin and postischemic myocardial injury.
Bianchi P; Kunduzova O; Masini E; Cambon C; Bani D; Raimondi L; Seguelas MH; Nistri S; Colucci W; Leducq N; Parini A
Circulation; 2005 Nov; 112(21):3297-305. PubMed ID: 16286591
[TBL] [Abstract][Full Text] [Related]
10. Autophagy signaling in cancer and its potential as novel target to improve anticancer therapy.
Moretti L; Yang ES; Kim KW; Lu B
Drug Resist Updat; 2007; 10(4-5):135-43. PubMed ID: 17627865
[TBL] [Abstract][Full Text] [Related]
11. New paradigms in anticancer therapy: targeting multiple signaling pathways with kinase inhibitors.
Faivre S; Djelloul S; Raymond E
Semin Oncol; 2006 Aug; 33(4):407-20. PubMed ID: 16890796
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic targeting of apoptosis pathways in cancer.
Ziegler DS; Kung AL
Curr Opin Oncol; 2008 Jan; 20(1):97-103. PubMed ID: 18043263
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis and non-apoptotic deaths in cancer development and treatment response.
de Bruin EC; Medema JP
Cancer Treat Rev; 2008 Dec; 34(8):737-49. PubMed ID: 18722718
[TBL] [Abstract][Full Text] [Related]
14. Key cancer cell signal transduction pathways as therapeutic targets.
Bianco R; Melisi D; Ciardiello F; Tortora G
Eur J Cancer; 2006 Feb; 42(3):290-4. PubMed ID: 16376541
[TBL] [Abstract][Full Text] [Related]
15. Role of death receptor and mitochondrial pathways in conventional chemotherapy drug induction of apoptosis.
Wang P; Song JH; Song DK; Zhang J; Hao C
Cell Signal; 2006 Sep; 18(9):1528-35. PubMed ID: 16442262
[TBL] [Abstract][Full Text] [Related]
16. Surviving cell death through epidermal growth factor (EGF) signal transduction pathways: implications for cancer therapy.
Henson ES; Gibson SB
Cell Signal; 2006 Dec; 18(12):2089-97. PubMed ID: 16815674
[TBL] [Abstract][Full Text] [Related]
17. Phosphatidylinositol 3-kinase inhibition broadly sensitizes glioblastoma cells to death receptor- and drug-induced apoptosis.
Opel D; Westhoff MA; Bender A; Braun V; Debatin KM; Fulda S
Cancer Res; 2008 Aug; 68(15):6271-80. PubMed ID: 18676851
[TBL] [Abstract][Full Text] [Related]
18. Cancer-specific toxicity of apoptin is independent of death receptors but involves the loss of mitochondrial membrane potential and the release of mitochondrial cell-death mediators by a Nur77-dependent pathway.
Maddika S; Booy EP; Johar D; Gibson SB; Ghavami S; Los M
J Cell Sci; 2005 Oct; 118(Pt 19):4485-93. PubMed ID: 16179607
[TBL] [Abstract][Full Text] [Related]
19. Insights into cardiovascular side-effects of modern anticancer therapeutics.
Stortecky S; Suter TM
Curr Opin Oncol; 2010 Jul; 22(4):312-7. PubMed ID: 20535072
[TBL] [Abstract][Full Text] [Related]
20. Apoptotic pathways and therapy resistance in human malignancies.
Viktorsson K; Lewensohn R; Zhivotovsky B
Adv Cancer Res; 2005; 94():143-96. PubMed ID: 16096001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
